• Je něco špatně v tomto záznamu ?

Validation and Update of the Lémann Index to Measure Cumulative Structural Bowel Damage in Crohn's Disease

B. Pariente, J. Torres, J. Burisch, N. Arebi, B. Barberio, D. Duricova, P. Ellul, A. Goldis, I. Kaimakliotis, K. Katsanos, Ž. Krznaric, D. McNamara, N. Pedersen, S. Sebastian, M. Azahaf, P. Weimers, P. Lung, C. Lacognata, M. Horak, D....

. 2021 ; 161 (3) : 853-864.e13. [pub] 20210528

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie, pozorovací studie, práce podpořená grantem, validační studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc22012242

Grantová podpora
K23 DK111995 NIDDK NIH HHS - United States

BACKGROUND & AIMS: The Lémann Index is a tool measuring cumulative structural bowel damage in Crohn's disease (CD). We reported on its validation and updating. METHODS: This was an international, multicenter, prospective, cross-sectional observational study. At each center, 10 inclusions, stratified by CD duration and location, were planned. For each patient, the digestive tract was divided into 4 organs, upper tract, small bowel, colon/rectum, anus, and subsequently into segments, explored systematically by magnetic resonance imaging and by endoscopies in relation to disease location. For each segment, investigators retrieved information on previous surgical procedures, identified predefined strictures and penetrating lesions of maximal severity (grades 1-3) at each organ investigational method (gastroenterologist and radiologist for magnetic resonance imaging), provided segmental damage evaluation ranging from 0.0 to 10.0 (complete resection). Organ resection-free cumulative damage evaluation was then calculated from the sum of segmental damages. Then investigators provided a 0-10 global damage evaluation from the 4-organ standardized cumulative damage evaluations. Simple linear regressions of investigator damage evaluations on their corresponding Lémann Index were studied, as well as calibration plots. Finally, updated Lémann Index was derived through multiple linear mixed models applied to combined development and validation samples. RESULTS: In 15 centers, 134 patients were included. Correlation coefficients between investigator damage evaluations and Lémann Indexes were >0.80. When analyzing data in 272 patients from both samples and 27 centers, the unbiased correlation estimates were 0.89, 0,97, 0,94, 0.81, and 0.91 for the 4 organs and globally, and stable when applied to one sample or the other. CONCLUSIONS: The updated Lémann Index is a well-established index to assess cumulative bowel damage in CD that can be used in epidemiological studies and disease modification trials.

American Gastroenterology Center Cyprus

Department of Gastroenterology Hepatology and Nutrition University Hospital Centre Zagreb Zagreb Croatia

Department of Gastroenterology Medical Division Hvidovre University Hospital Hvidovre Denmark

Department of Gastroenterology North Zealand University Hospital Capital Region Denmark

Department of Gastroenterology Slagelse Hospital Slagelse Denmark

Department of Gastroenterology University of Medicine Timișoara România

Department of Inflammatory Bowel Disease St Mark's Hospital and Imperial College London London United Kingdom

Department of Medicine Division of Gastroenterology Icahn School of Medicine at Mount Sinai New York New York

Department of Radiology Na Homolce Hospital Prague Czech Republic

Department of Radiology Tallaght University Hospital Dublin Ireland

Division of Gastroenterology Department of Internal Medicine Faculty of Medicine University of Ioannina School of Health Sciences Ioannina Greece

Division of Gastroenterology Department of Surgery Oncology and Gastroenterology University of Padova Padova Italy

Division of Gastroenterology Surgical Department Hospital Beatriz Ângelo Loures Portugal

Hepato Gastroenterology Department Claude Huriez Hospital University of Lille Lille France

Inflammatory Bowel Diseases Clinical and Research Center ISCARE a s Prague Czech Republic

Inflammatory Bowel Diseases Unit Hull University Teaching Hospitals National Health Service Trust Hull United Kingdom

INSERM U1135 Centre de Recherche Epidémiologie et Statistiques Equipe Epidemiology and Clinical Statistics for Tumor Respiratory and Resuscitation Assessments Université de Paris Hôpital Saint Louis Paris France

Institute of Pharmacology 1st Faculty of Medicine Charles University Prague Czech Republic

Mater Dei Hospital Department of Medicine Division of Gastroenterology Msida Malta

Radiology Department Claude Huriez hospital University of Lille Lille France

Radiology Department St Mark's Hospital and Imperial College London United Kingdom

Radiology Unit University of Padova Padova Italy

TAGG Research Centre School of Medicine Trinity College Dublin Dublin Ireland

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012242
003      
CZ-PrNML
005      
20220506125914.0
007      
ta
008      
220425s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1053/j.gastro.2021.05.049 $2 doi
035    __
$a (PubMed)34052277
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Pariente, Benjamin $u Hepato-Gastroenterology Department, Claude Huriez Hospital, University of Lille, Lille, France. Electronic address: benjamin.pariente@chru-lille.fr
245    10
$a Validation and Update of the Lémann Index to Measure Cumulative Structural Bowel Damage in Crohn's Disease / $c B. Pariente, J. Torres, J. Burisch, N. Arebi, B. Barberio, D. Duricova, P. Ellul, A. Goldis, I. Kaimakliotis, K. Katsanos, Ž. Krznaric, D. McNamara, N. Pedersen, S. Sebastian, M. Azahaf, P. Weimers, P. Lung, C. Lacognata, M. Horak, D. Christodoulou, V. Domislovic, I. Murphy, J. Lambert, R. Ungaro, JF. Colombel, JY. Mary
520    9_
$a BACKGROUND & AIMS: The Lémann Index is a tool measuring cumulative structural bowel damage in Crohn's disease (CD). We reported on its validation and updating. METHODS: This was an international, multicenter, prospective, cross-sectional observational study. At each center, 10 inclusions, stratified by CD duration and location, were planned. For each patient, the digestive tract was divided into 4 organs, upper tract, small bowel, colon/rectum, anus, and subsequently into segments, explored systematically by magnetic resonance imaging and by endoscopies in relation to disease location. For each segment, investigators retrieved information on previous surgical procedures, identified predefined strictures and penetrating lesions of maximal severity (grades 1-3) at each organ investigational method (gastroenterologist and radiologist for magnetic resonance imaging), provided segmental damage evaluation ranging from 0.0 to 10.0 (complete resection). Organ resection-free cumulative damage evaluation was then calculated from the sum of segmental damages. Then investigators provided a 0-10 global damage evaluation from the 4-organ standardized cumulative damage evaluations. Simple linear regressions of investigator damage evaluations on their corresponding Lémann Index were studied, as well as calibration plots. Finally, updated Lémann Index was derived through multiple linear mixed models applied to combined development and validation samples. RESULTS: In 15 centers, 134 patients were included. Correlation coefficients between investigator damage evaluations and Lémann Indexes were >0.80. When analyzing data in 272 patients from both samples and 27 centers, the unbiased correlation estimates were 0.89, 0,97, 0,94, 0.81, and 0.91 for the 4 organs and globally, and stable when applied to one sample or the other. CONCLUSIONS: The updated Lémann Index is a well-established index to assess cumulative bowel damage in CD that can be used in epidemiological studies and disease modification trials.
650    _2
$a dospělí $7 D000328
650    _2
$a kolonoskopie $7 D003113
650    _2
$a Crohnova nemoc $x diagnostické zobrazování $x patologie $x chirurgie $7 D003424
650    _2
$a průřezové studie $7 D003430
650    12
$a metody pro podporu rozhodování $7 D003661
650    12
$a gastrointestinální endoskopie $7 D016099
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a střeva $x diagnostické zobrazování $x patologie $x chirurgie $7 D007422
650    12
$a magnetická rezonanční tomografie $7 D008279
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a prospektivní studie $7 D011446
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a stupeň závažnosti nemoci $7 D012720
650    _2
$a počítačová rentgenová tomografie $7 D014057
651    _2
$a Evropa $7 D005060
651    _2
$a City of New York $7 D009519
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a validační studie $7 D023361
700    1_
$a Torres, Joana $u Division of Gastroenterology, Surgical Department, Hospital Beatriz Ângelo, Loures, Portugal
700    1_
$a Burisch, Johan $u Department of Gastroenterology, Medical Division, Hvidovre University Hospital, Hvidovre, Denmark
700    1_
$a Arebi, Naila $u Department of Inflammatory Bowel Disease, St Mark's Hospital and Imperial College London, London, United Kingdom
700    1_
$a Barberio, Brigida $u Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy
700    1_
$a Duricova, Dana $u Inflammatory Bowel Diseases Clinical and Research Center, ISCARE a.s., Prague, Czech Republic; Institute of Pharmacology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Ellul, Pierre $u Mater Dei Hospital, Department of Medicine, Division of Gastroenterology, Msida, Malta
700    1_
$a Goldis, Adrian $u Department of Gastroenterology, University of Medicine, Timișoara, România
700    1_
$a Kaimakliotis, Ioannis $u American Gastroenterology Center, Cyprus
700    1_
$a Katsanos, Konstantinos $u Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine University of Ioannina School of Health Sciences, Ioannina, Greece
700    1_
$a Krznaric, Željko $u Department of Gastroenterology, Hepatology and Nutrition, University Hospital Centre Zagreb, Zagreb, Croatia
700    1_
$a McNamara, Deirdre $u TAGG Research Centre, School of Medicine, Trinity College Dublin, Dublin, Ireland
700    1_
$a Pedersen, Natalia $u Department of Gastroenterology, Slagelse Hospital, Slagelse, Denmark
700    1_
$a Sebastian, Shaji $u Inflammatory Bowel Diseases Unit, Hull University Teaching Hospitals National Health Service Trust, Hull, United Kingdom
700    1_
$a Azahaf, Mustapha $u Radiology Department, Claude Huriez hospital, University of Lille, Lille, France
700    1_
$a Weimers, Petra $u Department of Gastroenterology, North Zealand University Hospital, Capital Region, Denmark
700    1_
$a Lung, Philip $u Radiology Department, St Mark's Hospital and Imperial College, London, United Kingdom
700    1_
$a Lacognata, Carmelo $u Radiology Unit, University of Padova, Padova, Italy
700    1_
$a Horak, Martin $u Department of Radiology, Na Homolce Hospital, Prague, Czech Republic
700    1_
$a Christodoulou, Dimitrios $u Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine University of Ioannina School of Health Sciences, Ioannina, Greece
700    1_
$a Domislovic, Viktor $u Department of Gastroenterology, Hepatology and Nutrition, University Hospital Centre Zagreb, Zagreb, Croatia
700    1_
$a Murphy, Ian $u Department of Radiology, Tallaght University Hospital, Dublin, Ireland
700    1_
$a Lambert, Jérôme $u INSERM U1135 Centre de Recherche Epidémiologie et Statistiques, Equipe Epidemiology and Clinical Statistics for Tumor, Respiratory, and Resuscitation Assessments, Université de Paris, Hôpital Saint-Louis, Paris, France
700    1_
$a Ungaro, Ryan $u Department of Medicine, Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York
700    1_
$a Colombel, Jean-Frédéric $u Department of Medicine, Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York
700    1_
$a Mary, Jean-Yves $u INSERM U1135 Centre de Recherche Epidémiologie et Statistiques, Equipe Epidemiology and Clinical Statistics for Tumor, Respiratory, and Resuscitation Assessments, Université de Paris, Hôpital Saint-Louis, Paris, France
773    0_
$w MED00001877 $t Gastroenterology $x 1528-0012 $g Roč. 161, č. 3 (2021), s. 853-864.e13
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34052277 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506125907 $b ABA008
999    __
$a ok $b bmc $g 1789711 $s 1163443
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 161 $c 3 $d 853-864.e13 $e 20210528 $i 1528-0012 $m Gastroenterology $n Gastroenterology $x MED00001877
GRA    __
$a K23 DK111995 $p NIDDK NIH HHS $2 United States
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...